| Literature DB >> 27467164 |
Bangyong Zhu1, Jin Bu2, Wei Li3, Jie Zhang3, Geng Huang3, Juan Cao3, Zhongshu Tang3, Quan Gan1, Pingjiang Wei1.
Abstract
Azithromycin is used as an alternative medicine in patients with syphilis who are intolerant to penicillin. Nevertheless, the report of treatment failure of azithromycin for patients with syphilis has raised concerns in China in the past years. In this study, 178 patients with early syphilis, who were treated in sexually transmitted infections clinics in four cities in Guangxi Zhuang Autonomous Region were enrolled to investigate the regional prevalence of Treponema pallidum strain resistant to azithromycin. Nested PCR was performed to amplify the 23S ribosomal RNA (23SrRNA) gene. The point mutation of A2058G in 23SrRNA, which confers Treponema pallidum resistance to azithromycin, was measured by endonuclease digestion of PCR amplification products using MboII. A2058G point mutation was detected in 91.0% (162/178; 95% CI, 86.8%, 95.2%) of the specimens, but no difference in prevalence of azithromycin resistance was found between the patients who had taken antibiotics before enrollment and the patients who had not (91.8% vs. 89.4%), nor between the patients with and without past sexually transmitted infections (87.1% vs. 93.1%). We concluded that azithromycin may not be suitable for syphilis as a treatment option in Guangxi Zhuang Autonomous Region because of the extremely high prevalence of resistance in the general syphilis population.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27467164 PMCID: PMC4965067 DOI: 10.1371/journal.pone.0159787
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers used in the study.
| Gene | Forward primer | Reverse primer |
|---|---|---|
| 5'-CAAGTCAGGACGGACTGTCC-3' | 5'-GGTATCACCTGGGGATGC-3' | |
| 5'-CAGGTTTTGCCGTTAAGC-3' | 5'-AATCAAGGGAGAATACCGTC-3' | |
| 5'-GGTCCCTATGATATCGTGTTCG-3' | 5'-GTCATGGATCTGCGAGTGG-3' |
Demographic characteristics of patients diagnosed with syphilis.
| Demographic characteristics | Total number | Value (95%CI) |
|---|---|---|
| 178 | 37.2±13.96 | |
| 141 | 79.21 (73.25, 85.17) | |
| 103 | 57.87 (50.63, 65.10) | |
| 122 | 68.0 (61.12, 74.83) | |
| 82 | 46.08 (38.74,53.79) | |
| 67 | 37.64 (30.52, 44.76) |
CI: confidence interval.
Sex behavioral and clinical and laboratory characteristics of patients diagnosed with syphilis (n = 178).
| Characteristics | Total Number | Value(95%CI) |
|---|---|---|
| | 147 | 82.58 (77.01,88.15) |
| | 152 | 85.39 (80.20, 90.58) |
| | 0 | NA |
| | 5 | 2.89 (0.42, 5.35) |
| | 101 | 56.7 (49.5,64.0) |
| | 32 | 8–64 |
| | 82 | 46.7 (38.7,53.4) |
| | 162 | 91.0 (86.8, 95.2) |
*Commercial sex behavior: exchange sex behavior for things like money, drugs, or other resources, the subject could provide the sex service or receive the sex service. IQR: indicates interquartile range; RPR, rapid plasma reagin; NA, not available.
History of STIs and macrolide use by patients (n = 178).
| Variable | Number | Resistance,%(95% CI) | OR | |
|---|---|---|---|---|
| | 62 | 87.1%(82.2%,92.0%) | 0.5 | 0.182 |
| | 116 | 93.1%(89.4%,96.8%) | —— | |
| | 159 | 91.8%(87.8%,95.8%) | 1.321 | 0.655 |
| | 19 | 89.4%(85.0%,92.9%) | —— |
STIs, sexually transmitted infections; CI, confidence interval; OR, odds ratios.